451 related articles for article (PubMed ID: 28094199)
1. Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based study.
Klemann N; Røder MA; Helgstrand JT; Brasso K; Toft BG; Vainer B; Iversen P
Lancet Oncol; 2017 Feb; 18(2):221-229. PubMed ID: 28094199
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
[TBL] [Abstract][Full Text] [Related]
3. Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy.
Park SJ; Miyake H; Hara I; Eto H
Int J Urol; 2003 Feb; 10(2):68-71. PubMed ID: 12588600
[TBL] [Abstract][Full Text] [Related]
4. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
[TBL] [Abstract][Full Text] [Related]
5. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate.
Fleshner NE; O'Sullivan M; Fair WR
J Urol; 1997 Aug; 158(2):505-8; discussion 508-9. PubMed ID: 9224334
[TBL] [Abstract][Full Text] [Related]
7. Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies.
Nafie S; Pal RP; Dormer JP; Khan MA
World J Urol; 2014 Aug; 32(4):971-5. PubMed ID: 24337167
[TBL] [Abstract][Full Text] [Related]
8. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
9. [Real-time elastography in the diagnosis of prostate cancer: personal experience].
Romagnoli A; Autieri G; Centrella D; Gastaldi C; Pedaci G; Rivolta L; Pozzi E; Anghileri A; Cerabino M; Bianchi CM; Roggia A
Urologia; 2010; 77(4):248-53. PubMed ID: 21234867
[TBL] [Abstract][Full Text] [Related]
10. A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup.
Kawa SM; Stroomberg HV; Larsen SB; Helgstrand JT; Toft BG; Vickers AJ; Brasso K; Røder MA
J Urol; 2022 Jul; 208(1):100-108. PubMed ID: 35212571
[TBL] [Abstract][Full Text] [Related]
11. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic differences between prostate cancers detected during initial and repeat transrectal ultrasound-guided biopsy in Korea.
Park DJ; Kim KH; Kwon TG; Kim CI; Park CH; Park JS; Kim DY; Kim JS; Moon KH; Lee KS
Korean J Urol; 2014 Nov; 55(11):718-24. PubMed ID: 25405013
[TBL] [Abstract][Full Text] [Related]
13. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2014 Sep; 15(10):1076-89. PubMed ID: 25130995
[TBL] [Abstract][Full Text] [Related]
14. Population-based outcomes of men with a single negative prostate biopsy: Importance of continued follow-up among older patients.
Sayyid RK; Alibhai SMH; Sutradhar R; Eberg M; Fung K; Klaassen Z; Goldberg H; Perlis N; Madi R; Terris MK; Urbach DR; Fleshner NE
Urol Oncol; 2019 May; 37(5):298.e19-298.e27. PubMed ID: 30770299
[TBL] [Abstract][Full Text] [Related]
15. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
[TBL] [Abstract][Full Text] [Related]
16. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
Remzi M; Dobrovits M; Reissigl A; Ravery V; Waldert M; Wiunig C; Fong YK; Djavan B;
Eur Urol; 2004 Oct; 46(4):451-6. PubMed ID: 15363559
[TBL] [Abstract][Full Text] [Related]
17. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer.
Levine MA; Ittman M; Melamed J; Lepor H
J Urol; 1998 Feb; 159(2):471-5; discussion 475-6. PubMed ID: 9649265
[TBL] [Abstract][Full Text] [Related]
18. Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance.
Eltemamy MM; Leapman MS; Cowan JE; Westphalen A; Shinohara K; Carroll PR
J Urol; 2016 Sep; 196(3):727-33. PubMed ID: 27117443
[TBL] [Abstract][Full Text] [Related]
19. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A
Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
